6/24/2013 8:01:17 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Cell Therapeutics Inc said the U.S. Food and Drug Administration has placed a partial clinical hold on the company's experimental blood cancer drug after the death of a patient. The patient, being treated with the drug tosedostat in combination with a chemotherapy drug, died of myocarditis, or infection of the heart muscle, the company said in a regulatory filing on Monday.
Help employers find you! Check out all the jobs and post your resume.
comments powered by